{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:07:10Z","timestamp":1760080030067},"reference-count":17,"publisher":"Media Sphere Publishing Group","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2016]]},"DOI":"10.17116\/oftalma2016132659-63","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T14:14:28Z","timestamp":1485267268000},"page":"59","source":"Crossref","is-referenced-by-count":6,"title":["Melatonin as a new promising agent for the treatment and prevention of retinopathy of prematurity"],"prefix":"10.17116","volume":"132","author":[{"given":"L. A.","family":"Katargina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. B.","family":"Chesnokova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. V.","family":"Beznos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Osipova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2016132659-63-1","unstructured":"Katargina L, Osipova N. The basic strategy of development an animal model of retinopathy of prematurity. Rossiiskaya Pediatricheskaya oftal'mologiya. 2014;1:56-60. (in Russ.)"},{"key":"key-10.17116\/oftalma2016132659-63-2","unstructured":"Hartnett ME. Studies on the Pathogenesis of Avascular Retina and Neovasculatization into the Vitreous in Peripheral Severe Retinopathy of Prematurity (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2010;108:96-119."},{"key":"key-10.17116\/oftalma2016132659-63-3","doi-asserted-by":"crossref","unstructured":"Grossniklaus HE, Kang SJ, Berglin L. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res. 2010;29(6):500-519.","DOI":"10.1016\/j.preteyeres.2010.05.003"},{"key":"key-10.17116\/oftalma2016132659-63-4","doi-asserted-by":"crossref","unstructured":"Dorfman A, Dembinska O, Chemtob S, Lachapelle P. Early Manifestations of Postnatal Hyperoxia on the Retinal Structure and Function of the Neonatal Rat. Invest Ophthalmol Vis Sci. 2008;49(1):458-466.","DOI":"10.1167\/iovs.07-0916"},{"key":"key-10.17116\/oftalma2016132659-63-5","doi-asserted-by":"crossref","unstructured":"Dorfman AL, Cuenca N, Pinilla I, Chemtob S, Lachapelle P. Immunohistochemical Evidence of Synaptic Retraction, Cytoarchitectural Remodeling, and Cell Death in the Inner Retina of the Rat Model of Oygen-Induced Retinopathy (OIR). Invest Ophthalmol Vis Sci. 2011;52(3):1693-1708.","DOI":"10.1167\/iovs.10-6197"},{"key":"key-10.17116\/oftalma2016132659-63-6","doi-asserted-by":"crossref","unstructured":"Barnett JM, Yanni SE, Penn JS. The Development of Rat Model of Retinopathy of Prematurity. Doc Ophthalmol. 2010;120(1):3-12.","DOI":"10.1007\/s10633-009-9180-y"},{"key":"key-10.17116\/oftalma2016132659-63-7","unstructured":"Cunningham S, McColm JR, Wade J, Sedowofia K, McIntosh N, Fleck B. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci. 2000;41(13):4275-4280."},{"key":"key-10.17116\/oftalma2016132659-63-8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/980374"},{"key":"key-10.17116\/oftalma2016132659-63-9","doi-asserted-by":"crossref","unstructured":"Siu AW, Maldonado M, Sanchez-Hidalgo M, Tan D-X, Reiter RJ. Protective effects of melatonin in experimental free radical-related ocular diseases. Journal of Pineal Research. 2006;40(2):101-109.","DOI":"10.1111\/j.1600-079X.2005.00304.x"},{"key":"key-10.17116\/oftalma2016132659-63-10","doi-asserted-by":"crossref","unstructured":"Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW, Kim YJ. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res. 2010;48(2):178-184.","DOI":"10.1111\/j.1600-079X.2009.00742.x"},{"key":"key-10.17116\/oftalma2016132659-63-11","doi-asserted-by":"crossref","unstructured":"Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, Ling EA. Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J. Pathol. 2007;212(4):429-439.","DOI":"10.1002\/path.2195"},{"key":"key-10.17116\/oftalma2016132659-63-12","doi-asserted-by":"crossref","unstructured":"Gulidova O Lubitsky O, Klebanov G, Chesnokova N. Changes of antioxidant activity in tears in experimental eye burns. Bulleten\u2019 Experimental\u2019noy Biologii i Mediciny. 1999;128(11):571-574. (In Russ.)","DOI":"10.1007\/BF02433426"},{"key":"key-10.17116\/oftalma2016132659-63-13","doi-asserted-by":"crossref","unstructured":"Lowry O, Rozebrough N, Farr A, Randell R. Protein m\u0435asurement with the folin phenol reagent. J Bio Chem. 1951;193:265-275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"key-10.17116\/oftalma2016132659-63-14","doi-asserted-by":"crossref","unstructured":"Berkowitz BA, Roberto KA, Penn JS. The vitreous protein concentration is increased prior to neovascularization in experimental ROP. Curr Eye Res. 1998;17:218-221.","DOI":"10.1076\/ceyr.17.2.218.5604"},{"key":"key-10.17116\/oftalma2016132659-63-15","doi-asserted-by":"crossref","unstructured":"Wiechmann AF, Summers JA. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues. Prog Retin Eye Res. 2008;27(2):137-160.","DOI":"10.1016\/j.preteyeres.2007.10.001"},{"key":"key-10.17116\/oftalma2016132659-63-16","doi-asserted-by":"crossref","unstructured":"Zhang H, Wang X, Xu K, Wang Y, Liu X, Zhang X, Wang L, Li X. 17\u03b2-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase. Biochem Biophys Res Commun. 2015;457(4):700-705.","DOI":"10.1016\/j.bbrc.2015.01.052"},{"key":"key-10.17116\/oftalma2016132659-63-17","doi-asserted-by":"crossref","unstructured":"Rivara S, Pala D, Bedini A, Spadoni G. Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012\u20142014). Expert Opin Ther Pat. 2015;25(4):425-441.","DOI":"10.1517\/13543776.2014.1001739"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T17:25:32Z","timestamp":1658510732000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2016\/6\/downloads\/ru\/10042465X2016061059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"alternative-id":["oftalma2016132659-63"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2016132659-63","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}